Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager

Ascendis Pharma A/S

NASDAQ:ASND

Watchlist

Price: 148.88 USD 1.56%

Market Cap: 8.5B USD

Have any thoughts about
Ascendis Pharma A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 148.88 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ASND Alert

Ascendis Pharma A/S

148.88

+2.29 (+1.56%)

52 Week Range	86.1 159.4
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Ascendis Pharma A/S

What unique competitive advantages
does Ascendis Pharma A/S hold over its rivals?

What risks and challenges
does Ascendis Pharma A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Ascendis Pharma A/S.

What unique competitive advantages
does Ascendis Pharma A/S hold over its rivals?

What risks and challenges
does Ascendis Pharma A/S face in the near future?

Summarize the latest earnings call
of Ascendis Pharma A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ascendis Pharma A/S.

Provide P/S
for Ascendis Pharma A/S.

Provide P/E
for Ascendis Pharma A/S.

Provide P/OCF
for Ascendis Pharma A/S.

Provide P/FCFE
for Ascendis Pharma A/S.

Provide P/B
for Ascendis Pharma A/S.

Provide EV/S
for Ascendis Pharma A/S.

Provide EV/GP
for Ascendis Pharma A/S.

Provide EV/EBITDA
for Ascendis Pharma A/S.

Provide EV/EBIT
for Ascendis Pharma A/S.

Provide EV/OCF
for Ascendis Pharma A/S.

Provide EV/FCFF
for Ascendis Pharma A/S.

Provide EV/IC
for Ascendis Pharma A/S.

Show me price targets
for Ascendis Pharma A/S made by professional analysts.

What are the Revenue projections
for Ascendis Pharma A/S?

How accurate were the past Revenue estimates
for Ascendis Pharma A/S?

What are the Net Income projections
for Ascendis Pharma A/S?

How accurate were the past Net Income estimates
for Ascendis Pharma A/S?

What are the EPS projections
for Ascendis Pharma A/S?

How accurate were the past EPS estimates
for Ascendis Pharma A/S?

What are the EBIT projections
for Ascendis Pharma A/S?

How accurate were the past EBIT estimates
for Ascendis Pharma A/S?

Compare the revenue forecasts
for Ascendis Pharma A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ascendis Pharma A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ascendis Pharma A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ascendis Pharma A/S compared to its peers.

Compare the P/E ratios
of Ascendis Pharma A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Ascendis Pharma A/S with its peers.

Analyze the financial leverage
of Ascendis Pharma A/S compared to its main competitors.

Show all profitability ratios
for Ascendis Pharma A/S.

Provide ROE
for Ascendis Pharma A/S.

Provide ROA
for Ascendis Pharma A/S.

Provide ROIC
for Ascendis Pharma A/S.

Provide ROCE
for Ascendis Pharma A/S.

Provide Gross Margin
for Ascendis Pharma A/S.

Provide Operating Margin
for Ascendis Pharma A/S.

Provide Net Margin
for Ascendis Pharma A/S.

Provide FCF Margin
for Ascendis Pharma A/S.

Show all solvency ratios
for Ascendis Pharma A/S.

Provide D/E Ratio
for Ascendis Pharma A/S.

Provide D/A Ratio
for Ascendis Pharma A/S.

Provide Interest Coverage Ratio
for Ascendis Pharma A/S.

Provide Altman Z-Score Ratio
for Ascendis Pharma A/S.

Provide Quick Ratio
for Ascendis Pharma A/S.

Provide Current Ratio
for Ascendis Pharma A/S.

Provide Cash Ratio
for Ascendis Pharma A/S.

What is the historical Revenue growth
over the last 5 years for Ascendis Pharma A/S?

What is the historical Net Income growth
over the last 5 years for Ascendis Pharma A/S?

What is the current Free Cash Flow
of Ascendis Pharma A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ascendis Pharma A/S.

ASND

Income Statement

Income from Continuing Operations

Ascendis Pharma A/S
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Ascendis Pharma A/S
Income from Continuing Operations Peer Comparison

Comparables:

GMAB

GLTO

BAVA

BIOPOR

SANION

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company		Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Ascendis Pharma A/S NASDAQ:ASND	Income from Continuing Operations -€489.5m	CAGR 3-Years -2%	CAGR 5-Years -22%	CAGR 10-Years N/A
	Genmab A/S NASDAQ:GMAB	Income from Continuing Operations kr5.5B	CAGR 3-Years 30%	CAGR 5-Years 36%	CAGR 10-Years 45%
	Galecto Inc NASDAQ:GLTO	Income from Continuing Operations -$38.3m	CAGR 3-Years -3%	CAGR 5-Years -19%	CAGR 10-Years N/A
B	Bavarian Nordic A/S CSE:BAVA	Income from Continuing Operations kr707.4m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Bioporto A/S CSE:BIOPOR	Income from Continuing Operations -kr50m	CAGR 3-Years 6%	CAGR 5-Years 0%	CAGR 10-Years -10%
	Saniona AB STO:SANION	Income from Continuing Operations -kr81.8m	CAGR 3-Years 39%	CAGR 5-Years -9%	CAGR 10-Years N/A

What is Ascendis Pharma A/S's Income from Continuing Operations?

Income from Continuing Operations
-489.5m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Income from Continuing Operations amounts to -489.5m EUR.

What is Ascendis Pharma A/S's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 5Y
-22%

Over the last year, the Income from Continuing Operations growth was 20%. The average annual Income from Continuing Operations growth rates for Ascendis Pharma A/S have been -2% over the past three years , -22% over the past five years .

Ascendis Pharma A/S
NASDAQ:ASND

Ascendis Pharma A/S
Income from Continuing Operations

Ascendis Pharma A/S
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

See Also

What is Ascendis Pharma A/S's Income from Continuing Operations?

Income from Continuing Operations
-489.5m EUR

What is Ascendis Pharma A/S's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 5Y
-22%

Company

Help

Tools

Stocks

Ascendis Pharma A/S NASDAQ:ASND

Ascendis Pharma A/S Income from Continuing Operations

Ascendis Pharma A/S Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis Latest Figures & CAGR of Competitors

See Also

What is Ascendis Pharma A/S's Income from Continuing Operations? Income from Continuing Operations -489.5m EUR

What is Ascendis Pharma A/S's Income from Continuing Operations growth rate? Income from Continuing Operations CAGR 5Y -22%

Company

Help

Tools

Stocks

Ascendis Pharma A/S
NASDAQ:ASND

Ascendis Pharma A/S
Income from Continuing Operations

Ascendis Pharma A/S
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

What is Ascendis Pharma A/S's Income from Continuing Operations?

Income from Continuing Operations
-489.5m EUR

What is Ascendis Pharma A/S's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 5Y
-22%